http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5268363-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8121 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate | 1992-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba651c6d543681b4684f01f3f1da2f9 |
| publicationDate | 1993-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5268363-A |
| titleOfInvention | Method of treatment to inhibit the undesirable activation of the complement cascade with factor J, an inhibitor of complement C1 |
| abstract | A purified protein, factor J, which has inhibitory properties which prevent the formation or the dissociation of Cl complex and a method of purification for said protein. The method including the following sequential chromatography steps: anion exchange QAE-"SEPHADEX", heparin-"SEPHAROSE" affinity, "MONO Q" and hydroxylapatite. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7109354-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004009995-A1 |
| priorityDate | 1989-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.